Allogene Therapeutics
ALLO
#8751
Rank
NZ$0.39 B
Marketcap
NZ$1.15
Share price
-5.88%
Change (1 day)
-47.62%
Change (1 year)

EPS for Allogene Therapeutics (ALLO)

EPS in 2026 (TTM): NZ-$1.16

According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$1.22. In 2025 the company made an earnings per share (EPS) of NZ-$1.59 an increase over its 2024 EPS that were of NZ-$2.43.

EPS history for Allogene Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.16-26.86%
2025NZ-$1.59-34.59%
2024NZ-$2.43
2022NZ-$4.2422.75%
2021NZ-$3.45-9.13%
2020NZ-$3.8014.92%
2019NZ-$3.31-9.42%
2018NZ-$3.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA